2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tangso KJ et al. | Novel spiropyran amphiphiles and their application as light-responsive liquid crystalline components. | 2013 | J Phys Chem B | pmid:23909814 |
| Hauss DJ et al. | Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. | 1998 | J Pharm Sci | pmid:9519148 |
| Ruela AL et al. | Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment. | 2016 | J Pharm Sci | pmid:26852841 |
| Ilardia-Arana D et al. | Biorelevant dissolution media: aggregation of amphiphiles and solubility of estradiol. | 2006 | J Pharm Sci | pmid:16374874 |
| Kararli TT and Gupta VW | Solubilization and dissolution properties of a leukotriene-D4 antagonist in micellar solutions. | 1992 | J Pharm Sci | pmid:1403686 |
| Rosenblatt KM et al. | Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. | 2007 | J Pharm Sci | pmid:17094136 |
| Bonacucina G et al. | Rheological and dielectric characterization of monoolein/water mesophases in the presence of a peptide drug. | 2005 | J Pharm Sci | pmid:16200546 |
| Puglia C et al. | Evaluation of monooleine aqueous dispersions as tools for topical administration of curcumin: characterization, in vitro and ex-vivo studies. | 2013 | J Pharm Sci | pmid:23686742 |
| Alfons K and Engstrom S | Drug compatibility with the sponge phases formed in monoolein, water, and propylene glycol or poly(ethylene glycol). | 1998 | J Pharm Sci | pmid:10189260 |
| He R and Craig DQ | Characterization of the effects of drug addition on the structure of glyceryl monoolein/water gel systems using low frequency dielectric spectroscopy. | 1999 | J Pharm Sci | pmid:10350501 |
| Muheem A et al. | A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations. | 2017 | J Pharm Sci | pmid:28552692 |
| Souza C et al. | Mucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochloride. | 2014 | J Pharm Sci | pmid:25336429 |
| Rossetti FC et al. | Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: evaluation of drug and pharmaceutical additives influence on the internal structure. | 2011 | J Pharm Sci | pmid:21337546 |
| Rizwan SB et al. | Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. | 2009 | J Pharm Sci | pmid:19340889 |
| Dante MCL et al. | Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies. | 2018 | J Pharm Sci | pmid:29108729 |
| Gabr MM et al. | Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study. | 2017 | J Pharm Sci | pmid:28479357 |
| Jia JX and Wasan KM | Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells. | 2008 | J Pharm Pharm Sci | pmid:18801307 |
| Totani N et al. | Ferulic acid esters and weight-loss promoting effects in rats. | 2012 | J Oleo Sci | pmid:22687778 |
| Tamayo-Esquivel D et al. | Evaluation of the enhanced oral effect of omapatrilat-monolein nanoparticles prepared by the emulsification-diffusion method. | 2006 Sep-Oct | J Nanosci Nanotechnol | pmid:17048528 |
| Lopes I et al. | Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells. | 2016 | J Liposome Res | pmid:26340109 |